This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Quest Diagnostics Inc (DGX)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 7.15B 7.38B 7.51B 7.37B
Cost of Sales 4.12B 4.15B 4.18B 4.10B
Gross Operating Profit 3.02B 3.23B 3.33B 3.27B
Selling, General, and Administrative Expenses 1.70B 1.75B 1.81B 1.71B
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 1.32B 1.48B 1.51B 1.56B
Depreciation & Amortization 283.00M 286.60M 281.10M 253.96M
Interest Income 3.00M 3.00M 2.77M 1.41M
Other Income - Net 482.00M 6.66M -235.95M -3.92M
Special Income / Charges -36.00M 2.88M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 1.51B 1.24B 1.03B 1.33B
Interest Expense 162.00M 167.69M 173.35M 147.50M
Pre-Tax Income 1.35B 1.07B 856.23M 1.18B
Income Taxes 500.00M 401.90M 349.00M 425.53M
Minority Interest 34.00M 36.41M 35.08M 36.12M
Net Income From Continuing Operations 848.00M 666.50M 507.23M 758.80M
Net Income From Discontinued Operations 35.00M -74.36M -1.58M -1.79M
Net Income From Total Operations 883.00M 592.13M 505.65M 757.02M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 849.00M 555.72M 470.57M 720.89M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
884.00M 663.62M 507.23M 758.80M
Preferred Dividends
Net Income Available To Common 848.00M 666.50M 507.23M 758.80M
Basic EPS from Continuing Ops. 5.35 3.96 2.96 4.09
Basic EPS from Discontinued Ops. 0.23 -0.47 -0.01 -0.01
Basic EPS from Total Operations 5.58 3.49 2.95 4.08
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 5.58 3.49 2.95 4.08
Basic Normalized Net Income/Share 5.58 3.94 2.96 4.09
EPS fr Continuing Ops. 5.31 3.92 2.93 4.06
EPS fr Discontinued Ops 0.23 -0.47 -0.01 -0.01
EPS fr Total Ops. 5.54 3.45 2.92 4.05
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.01 0.00 0.00
EPS, Total 5.54 3.46 2.92 4.05
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.54 3.90 2.93 4.06
Dividends Paid per Share 1.20 0.68 0.40 0.40
DGX News

DGX Quest Diagnostics Inc

Analysts Ratings for DGX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 13 13 13 13
Moderate Sell 0 0 0 0
Strong Sell 3 3 3 3
GET DGX ANALYST REPORT

Brokerage Partners

DGX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs